Author: Elise Evers

Elise has five years of consultancy experience as a health economist and in HTA strategy in various therapeutic areas, including rare pediatric diseases. She has extensive expertise in economic modelling and preparing comprehensive reimbursement submission dossiers for HTA bodies across the globe. Her background in health economics, combined with her current focus on HTA strategy, positions her to deliver impactful evidence to support access for innovative therapies. Elise holds an MSc in Health Economics from the University of York.